NEWS DETAIL

93 monarchE: Keputusan Kemandirian Keseluruhan Utama Terapi Adjuvan Abemaciclib + Endokrin untuk Kanser Payudara Awal HR+/HER2−, Berisiko Tinggi – CancerNetwork

93 monarchE: Primary Overall Survival Results of Adjuvant Abemaciclib + Endocrine Therapy for HR+/HER2−, High-Risk, Early Breast Cancer CancerNetwork

Maklumat Perubatan

该文章暂未提取到完整正文,已从资讯列表和商品关联资讯中自动隐藏。你可以返回文章列表继续浏览其他内容。

المنتجات المرتبطة بهذا المقال

تمت مطابقة هذه المنتجات تلقائيا استنادا الى عنوان المقال وملخصه ومحتواه.

الاسئلة الشائعة

Which products are related to this article?

The system matched these relevant products from the article content: لوسيوس أبيماسيكليب – اشترِ عبر الإنترنت BESIDX Abemaciclib.

How can I view the medicines discussed in this article?

Use the related product cards below the article to review available specifications, prices, product information, and reviews.

Does this article replace advice from a doctor or pharmacist?

No. This content is for general information and health education only. Follow the prescription and individual guidance provided by qualified healthcare professionals.

WhatsApp WhatsApp WeChat WeChat